Low mannose-binding lectin (MBL) levels and MBL genetic polymorphisms associated with the risk of neonatal sepsis: An updated meta-analysis

Early Human Development

Volumn 90, Issue 10, 2014, Pages 557-564

  Luo, Jun ^a,b   Xu, Fen ^b   Lu, Guang Jin ^b   Lin, Hung Chih ^c   Feng, Zhi Chun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Department of Neonatology   (China)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Mannose binding lectin; Meta analysis; Neonatal sepsis; Polymorphism

Indexed keywords

MANNOSE BINDING LECTIN;

ARTICLE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; META ANALYSIS; NEWBORN; NEWBORN SEPSIS; PREMATURITY; RISK FACTOR; SYSTEMATIC REVIEW; AREA UNDER THE CURVE; BLOOD; GENETICS; INFANT, NEWBORN, DISEASES; RISK; SEPSIS;

AREA UNDER CURVE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MANNOSE-BINDING LECTIN; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SEPSIS;

EID: 84922278935     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.07.007     Document Type: Article

References (31)

1. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110(2):285-291. [PubMed:12165580].
2. Mitha A., Foix-L'Hélias L., Arnaud C., Marret S., Vieux R., Aujard Y., et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics 2013, 132(2):e372-380. [PubMed: 23878051].
3. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13(1):11-16. [PubMed: 1739426].
4. Takahashi K., Ip W.E., Michelow I.C., Ezekowitz R.A. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 2006, 18(1):16-23. [PubMed: 16368230].
5. Kilpatrick D.C. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002, 12(6):335-352. [PubMed: 12473150].
6. Wagner T.A., Gravett C.A., Healy S., Soma V., Patterson J.C., Gravett M.G., et al. Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings. J Global Health 2011, 1(2):210-223. [PubMed: 23198120].
7. Frakking F.N., Brouwer N., Zweers D., et al. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 2006, 145(1):5-12. [PubMed: 16792667].
8. Hilgendorff A., Schmidt R., Bohnert A., Merz C., Bein G., Gortner L. Host defence lectins in preterm neonates. Acta Paediatr 2005, 94(6):794-799. [PubMed: 16188791].
9. Özkan H., Köksal N., Çetinkaya M., Kiliç Ş., Çelebi S., Oral B., et al. Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia. J Perinatol 2012, 32(3):210-217. [PubMed: 21681178].
10. Wahab Mohamed W.A., Saeed M.A. Mannose-binding lectin serum levels in neonatal sepsis and septic shock. J Matern Fetal Neonatal Med 2012, 25(4):411-414. [PubMed: 21631240].
11. Ahrens P., Kattner E., Köhler B., Härtel C., Seidenberg J., Segerer H., et al. Genetic factors in Neonatology Study Group. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004, 55(4):652-656. [PubMed: 14739370].
12. van der Zwet W.C., Catsburg A., van Elburg R.M., Savelkoul P.H., Vandenbroucke-Grauls C.M. Mannose-binding lectin (MBL) genotype in relation to risk of nosocomial infection in preterm neonates in the neonatal intensive care unit. Clin Microbiol Infect 2008, 14(2):130-135. [PubMed: 21142772].
13. Hilgendorff A., Heidinger K., Pfeiffer A., Bohnert A., König I.R., Ziegler A., et al. Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants. Genes Immunol 2007, 8(8):671-677. [PubMed: 17898783].
14. De Pascale G., Cutuli S.L., Pennisi M.A., Antonelli M. The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm 2013, 1-8. [PubMed: 24223476].
15. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. [PubMed: 14606960].
16. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., Bossuyt P.M.M. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56(11):1129-1135. [PubMed: 14615004].
17. Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560. [PubMed: 12958120].
18. Walter S.D. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002, 21(9):1237-1256. [PubMed: 12111876].
19. Borghesi A., Tzialla C., Decembrino L., Manzoni P., Stronati M. New possibilities of prevention of infection in the newborn. J Matern Fetal Neonatal Med 2011, 24:28-30. [PubMed: 21749301].
20. Takahashi K. Lessons learned from murine models of mannose-binding lectin deficiency. Biochem Soc Trans 2008, 36(Pt 6):1487-1490. [PubMed: 19021581].
21. Gordon C., Waheed U., Hansen K., Hitman A., Garrard S., Turner W., et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock 2006, 25(1):88-93. [PubMed: 16369192].
22. Garred P., Strom J., Quist L., Taaning E., Madsen H.O. Association of mannose binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003, 188(9):1394-1403. [PubMed: 14593599].
23. Fidler K.J., Wilson P., Davies J.C., Turner M.W., Peters M.W., Klein N.J. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 2004, 30(7):1438-1445. [PubMed: 15127191].
24. Ozdemir O., Dinleyici E.C., Tekin N., Colak O., Aksit M.A. Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2010, 23(9):1009-1013. [PubMed: 20067428].
25. Auriti C., Prencipe G., Inglese R., Azzari C., Ronchetti M.P., Tozzi A., et al. Role of mannose-binding lectin in nosocomial sepsis in critically ill neonates. Hum Immunol 2010, 71(11):1084-1088. [PubMed: 20732365].
26. Dzwonek A.B., Neth O.W., Thiébaut R., Gulczynska E., Chilton M., Hellwig T., et al. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr Res 2008, 63(6):680-685. [PubMed: 18317236].
27. Koroglu O.A., Onay H., Erdemir G., Yalaz M., Cakmak B., Akisu M., et al. Mannose-binding lectin gene polymorphism and early neonatal outcome in preterm infants. Neonatology 2010, 98(4):305-312. [PubMed: 20453525].
28. Israëls J., Frakking F.N., Kremer L.C., Offringa M., Kuijpers T.W., van de Wetering M.D. Mannose-binding lectin and infection risk in newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed 2010, 95(6):F452-F461. [PubMed: 20488866].
29. Frakking F.N., Brouwer N., van Eijkelenburg N.K., Merkus M.P., Kuijpers T.W., Offringa M., et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol 2007, 150(2):255-262. [PubMed: 17711490].
30. De Benedetti F., Auriti C., D'Urbano E., Ronchetti P., Rava L., Tozzi A., et al. Low serum levels of mannose binding lectin are a risk factor of neonatal sepsis. Pediatr Res 2007, 61(3):325-328. [PubMed: 17314691].
31. Kielgast S., Thiel S., Henriksen T.B., Bjerke T., Olsen J., Jensenius J.C. Umbilical cord mannan-binding lectin and infections in early childhood. Scand J Immunol 2003, 57(2):167-172. [PubMed: 12588663].